About CellCept-Myofortic
CellCept and Myofortic Linked to Pregnancy Loss and Birth Defects

The FDA has issued a warning to healthcare providers and patients that use of the drugs CellCept (mycophenolate mofetil) and Myofortic (mycophenolic acid) during pregnancy is associated with an increased risk of first trimester pregnancy loss and congenital malformations, particularly external ear and facial abnormalities including cleft lip and palate, and anomalies of the distal limbs, heart, esophagus, and kidney.

Related Tags of CellCept-Myofortic
CellCept and Myofortic lawsuit, birth defects, first trimester pregnancy loss and congenital malformations, particularly external ear and facial abnormalities including cleft lip and palate, and anom

Financial Assistance by Condition

Financial Assistance by Medication

Contact at info@medrxhelp.org

©Copyright MedRxHelp - 2014 - All Rights Reserved. All Ailments & Drugs